Skip to main content
Caplight Logo









Starbem

Starbem

Private
São PauloHealthcare & Life Scienceshttps://starbem.app/

Last Round

Seed

Oct 10, 2023

Est. Valuation

$2M

Total Funding Raised

$1.69M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Starbem operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Seed round in October 2023.

Starbem is a health technology company that provides a telemedicine platform offering video consultations with psychologists, nutritionists, and other medical specialists.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Mental Health, Patient Engagement, HR, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Starbem Comparables

Compare Starbem with similar companies based on industry and business-model similarity.

Starbem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OrienteMe
79%
Avus
78%
Guia da Alma
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Starbem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 10, 2023
AcceleratorSep 22, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Starbem Investors

Notable investors and investment history

Starbem investors
InvestorRounds
TechstarsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 48% MoM.

  • Aug 21, 2026

    Grew 16% QoQ, from 156 to 181 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Starbem Filings

Explore SEC and related filing metadata, where available.

Starbem filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Starbem's valuation, stock price, and market status.

Is Starbem a public or private company?

Starbem is a private company.

What is the current stock price of Starbem?

Starbem is a private company, so its shares have no public market price. Caplight tracks Starbem's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Starbem worth (valuation)?

Starbem's valuation is estimated at $2.0M based on funding round data.

Can I buy Starbem stock?

Starbem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Starbem's last funding round?

Starbem's most recent funding round was Seed on October 10, 2023.

Who are the main investors in Starbem?

Key investors in Starbem include Techstars.

Will Starbem IPO soon?

No public IPO plans have been announced for Starbem.

How can I track Starbem secondary market activity?

Caplight tracks bids, offers, and trades in Starbem's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range135
Year Founded2020
Last FundingOct 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?